HEADER    NEUROPEPTIDE                            09-JUN-03   1PLW              
TITLE     NMR STRUCTURE OF METHIONINE-ENKEPHALIN IN FAST TUMBLING               
TITLE    2 DMPC/DHPC BICELLES                                                   
COMPND    MOL_ID: 1;                                                            
COMPND   2 MOLECULE: MET-ENKEPHALIN 1;                                          
COMPND   3 CHAIN: A;                                                            
COMPND   4 ENGINEERED: YES                                                      
SOURCE    MOL_ID: 1;                                                            
SOURCE   2 SYNTHETIC: YES;                                                      
SOURCE   3 OTHER_DETAILS: THE PEPETIDE WAS CHEMICALLY SYNTHESIZED.              
SOURCE   4 THE SEQUENCE OF THE PEPTIDE IS NATURALLY FOUND IN HOMO               
SOURCE   5 SAPIENS (HUMAN)                                                      
KEYWDS    PEPTIDE, NEUROPEPTIDE                                                 
EXPDTA    SOLUTION NMR                                                          
NUMMDL    1                                                                     
AUTHOR    I.MARCOTTE,F.SEPAROVIC,M.AUGER,S.M.GAGNE                              
REVDAT   2   24-FEB-09 1PLW    1       VERSN                                    
REVDAT   1   16-MAR-04 1PLW    0                                                
JRNL        AUTH   I.MARCOTTE,F.SEPAROVIC,M.AUGER,S.M.GAGNE                     
JRNL        TITL   A MULTIDIMENSIONAL (1)H NMR INVESTIGATION OF THE             
JRNL        TITL 2 CONFORMATION OF METHIONINE-ENKEPHALIN IN                     
JRNL        TITL 3 FAST-TUMBLING BICELLES.                                      
JRNL        REF    BIOPHYS.J.                    V.  86  1587 2004              
JRNL        REFN                   ISSN 0006-3495                               
JRNL        PMID   14990485                                                     
REMARK   1                                                                      
REMARK   2                                                                      
REMARK   2 RESOLUTION. NOT APPLICABLE.                                          
REMARK   3                                                                      
REMARK   3 REFINEMENT.                                                          
REMARK   3   PROGRAM     : CNS 1.1                                              
REMARK   3   AUTHORS     : AXEL T. BRUNGER                                      
REMARK   3                                                                      
REMARK   3  OTHER REFINEMENT REMARKS: THE STRUCTURES ARE BASED ON A TOTAL       
REMARK   3  OF 2 PHI ANGLE AND 57 NOE-DERIVED DISTANCE CONSTRAINTS. 1000        
REMARK   3  HIGH-TEMPERATURE STEPS WERE USED (15 PS) UP TO A FINAL              
REMARK   3  TEMPERATURE OF 50000 K THEN 1000 COOLING STEPS (250 K, 15 PS)       
REMARK   3  WERE APPLIED. FINALLY, 10 CYCLES OF 200 MINIMIZATION STEPS          
REMARK   3  WERE PERFORMED. A REPEL CONSTANT VALUE OF 0.8 WAS USED              
REMARK   4                                                                      
REMARK   4 1PLW COMPLIES WITH FORMAT V. 3.15, 01-DEC-08                         
REMARK 100                                                                      
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 12-JUN-03.                  
REMARK 100 THE RCSB ID CODE IS RCSB019412.                                      
REMARK 210                                                                      
REMARK 210 EXPERIMENTAL DETAILS                                                 
REMARK 210  EXPERIMENT TYPE                : NMR                                
REMARK 210  TEMPERATURE           (KELVIN) : 295                                
REMARK 210  PH                             : 4.5                                
REMARK 210  IONIC STRENGTH                 : 9MM                                
REMARK 210  PRESSURE                       : AMBIENT                            
REMARK 210  SAMPLE CONTENTS                : 5.4UM MENK; DMPC/DHPC: 0.5:1       
REMARK 210                                   (MOLAR RATIO); LIPID/PEPTIDE:      
REMARK 210                                   25:1 (MOLAR RATIO); 10% W/V OF     
REMARK 210                                   LIPIDS IN WATER; 90%H2O, 10%D2O    
REMARK 210                                                                      
REMARK 210  NMR EXPERIMENTS CONDUCTED      : 2D NOESY, G-COSY                   
REMARK 210  SPECTROMETER FIELD STRENGTH    : 600 MHZ                            
REMARK 210  SPECTROMETER MODEL             : INOVA                              
REMARK 210  SPECTROMETER MANUFACTURER      : VARIAN                             
REMARK 210                                                                      
REMARK 210  STRUCTURE DETERMINATION.                                            
REMARK 210   SOFTWARE USED                 : VNMR 6.1C, NMRPIPE 2.0 REV         
REMARK 210                                   2001.117.12.48, NMRVIEW 5.0.4,     
REMARK 210                                   CNS 1.1                            
REMARK 210   METHOD USED                   : SIMULATED ANNEALING                
REMARK 210                                                                      
REMARK 210 CONFORMERS, NUMBER CALCULATED   : 200                                
REMARK 210 CONFORMERS, NUMBER SUBMITTED    : 80                                 
REMARK 210 CONFORMERS, SELECTION CRITERIA  : STRUCTURES WITH THE LOWEST         
REMARK 210                                   ENERGY                             
REMARK 210                                                                      
REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1                   
REMARK 210                                                                      
REMARK 210 REMARK: PFG EXPERIMENTS WERE ALSO PERFORMED ON THE SAMPLE            
REMARK 215                                                                      
REMARK 215 NMR STUDY                                                            
REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION           
REMARK 215 NMR DATA.  PROTEIN DATA BANK CONVENTIONS REQUIRE THAT                
REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON              
REMARK 215 THESE RECORDS ARE MEANINGLESS.                                       
REMARK 900                                                                      
REMARK 900 RELATED ENTRIES                                                      
REMARK 900 RELATED ID: 1PLX   RELATED DB: PDB                                   
REMARK 900 THE SAME PEPTIDE IN FAST TUMBLING BICELLES/DMPG                      
DBREF  1PLW A    1     5  UNP    P01210   PENK_HUMAN     100    104             
SEQRES   1 A    5  TYR GLY GLY PHE MET                                          
CRYST1    1.000    1.000    1.000  90.00  90.00  90.00 P 1           1          
ORIGX1      1.000000  0.000000  0.000000        0.00000                         
ORIGX2      0.000000  1.000000  0.000000        0.00000                         
ORIGX3      0.000000  0.000000  1.000000        0.00000                         
SCALE1      1.000000  0.000000  0.000000        0.00000                         
SCALE2      0.000000  1.000000  0.000000        0.00000                         
SCALE3      0.000000  0.000000  1.000000        0.00000                         
MODEL        1                                                                  
ATOM      1  N   TYR A   1       1.745   3.982   3.628  1.00  0.00           N  
ATOM      2  CA  TYR A   1       0.807   3.643   2.527  1.00  0.00           C  
ATOM      3  C   TYR A   1       0.956   4.609   1.356  1.00  0.00           C  
ATOM      4  O   TYR A   1       1.689   5.595   1.440  1.00  0.00           O  
ATOM      5  CB  TYR A   1      -0.622   3.693   3.070  1.00  0.00           C  
ATOM      6  CG  TYR A   1      -1.629   2.970   2.205  1.00  0.00           C  
ATOM      7  CD1 TYR A   1      -1.703   1.583   2.200  1.00  0.00           C  
ATOM      8  CD2 TYR A   1      -2.504   3.678   1.390  1.00  0.00           C  
ATOM      9  CE1 TYR A   1      -2.622   0.921   1.407  1.00  0.00           C  
ATOM     10  CE2 TYR A   1      -3.426   3.023   0.595  1.00  0.00           C  
ATOM     11  CZ  TYR A   1      -3.480   1.645   0.607  1.00  0.00           C  
ATOM     12  OH  TYR A   1      -4.396   0.991  -0.184  1.00  0.00           O  
ATOM     13  H1  TYR A   1       1.508   4.937   3.963  1.00  0.00           H  
ATOM     14  H2  TYR A   1       2.711   3.948   3.242  1.00  0.00           H  
ATOM     15  H3  TYR A   1       1.616   3.279   4.382  1.00  0.00           H  
ATOM     16  HA  TYR A   1       1.022   2.641   2.187  1.00  0.00           H  
ATOM     17  HB2 TYR A   1      -0.643   3.241   4.049  1.00  0.00           H  
ATOM     18  HB3 TYR A   1      -0.932   4.724   3.147  1.00  0.00           H  
ATOM     19  HD1 TYR A   1      -1.030   1.018   2.827  1.00  0.00           H  
ATOM     20  HD2 TYR A   1      -2.458   4.756   1.382  1.00  0.00           H  
ATOM     21  HE1 TYR A   1      -2.665  -0.158   1.417  1.00  0.00           H  
ATOM     22  HE2 TYR A   1      -4.096   3.591  -0.032  1.00  0.00           H  
ATOM     23  HH  TYR A   1      -5.275   1.335  -0.009  1.00  0.00           H  
ATOM     24  N   GLY A   2       0.256   4.318   0.266  1.00  0.00           N  
ATOM     25  CA  GLY A   2       0.315   5.161  -0.907  1.00  0.00           C  
ATOM     26  C   GLY A   2      -0.088   4.423  -2.169  1.00  0.00           C  
ATOM     27  O   GLY A   2      -0.467   5.041  -3.163  1.00  0.00           O  
ATOM     28  H   GLY A   2      -0.309   3.524   0.260  1.00  0.00           H  
ATOM     29  HA2 GLY A   2      -0.351   5.997  -0.764  1.00  0.00           H  
ATOM     30  HA3 GLY A   2       1.323   5.529  -1.023  1.00  0.00           H  
ATOM     31  N   GLY A   3      -0.011   3.095  -2.127  1.00  0.00           N  
ATOM     32  CA  GLY A   3      -0.380   2.294  -3.278  1.00  0.00           C  
ATOM     33  C   GLY A   3       0.790   1.523  -3.855  1.00  0.00           C  
ATOM     34  O   GLY A   3       1.037   1.563  -5.060  1.00  0.00           O  
ATOM     35  H   GLY A   3       0.295   2.657  -1.304  1.00  0.00           H  
ATOM     36  HA2 GLY A   3      -1.142   1.591  -2.981  1.00  0.00           H  
ATOM     37  HA3 GLY A   3      -0.781   2.943  -4.043  1.00  0.00           H  
ATOM     38  N   PHE A   4       1.508   0.816  -2.991  1.00  0.00           N  
ATOM     39  CA  PHE A   4       2.655   0.026  -3.411  1.00  0.00           C  
ATOM     40  C   PHE A   4       2.341  -1.461  -3.298  1.00  0.00           C  
ATOM     41  O   PHE A   4       2.771  -2.264  -4.126  1.00  0.00           O  
ATOM     42  CB  PHE A   4       3.879   0.358  -2.553  1.00  0.00           C  
ATOM     43  CG  PHE A   4       3.758   1.637  -1.773  1.00  0.00           C  
ATOM     44  CD1 PHE A   4       4.135   2.846  -2.331  1.00  0.00           C  
ATOM     45  CD2 PHE A   4       3.267   1.622  -0.478  1.00  0.00           C  
ATOM     46  CE1 PHE A   4       4.023   4.021  -1.611  1.00  0.00           C  
ATOM     47  CE2 PHE A   4       3.154   2.790   0.247  1.00  0.00           C  
ATOM     48  CZ  PHE A   4       3.532   3.992  -0.319  1.00  0.00           C  
ATOM     49  H   PHE A   4       1.258   0.823  -2.044  1.00  0.00           H  
ATOM     50  HA  PHE A   4       2.867   0.265  -4.442  1.00  0.00           H  
ATOM     51  HB2 PHE A   4       4.032  -0.440  -1.844  1.00  0.00           H  
ATOM     52  HB3 PHE A   4       4.746   0.438  -3.192  1.00  0.00           H  
ATOM     53  HD1 PHE A   4       4.519   2.868  -3.340  1.00  0.00           H  
ATOM     54  HD2 PHE A   4       2.971   0.683  -0.035  1.00  0.00           H  
ATOM     55  HE1 PHE A   4       4.320   4.959  -2.055  1.00  0.00           H  
ATOM     56  HE2 PHE A   4       2.768   2.764   1.255  1.00  0.00           H  
ATOM     57  HZ  PHE A   4       3.445   4.908   0.246  1.00  0.00           H  
ATOM     58  N   MET A   5       1.590  -1.815  -2.261  1.00  0.00           N  
ATOM     59  CA  MET A   5       1.215  -3.202  -2.022  1.00  0.00           C  
ATOM     60  C   MET A   5       0.151  -3.657  -3.016  1.00  0.00           C  
ATOM     61  O   MET A   5      -0.183  -2.869  -3.926  1.00  0.00           O  
ATOM     62  CB  MET A   5       0.700  -3.371  -0.590  1.00  0.00           C  
ATOM     63  CG  MET A   5       1.561  -2.682   0.457  1.00  0.00           C  
ATOM     64  SD  MET A   5       2.792  -3.785   1.178  1.00  0.00           S  
ATOM     65  CE  MET A   5       4.246  -2.740   1.142  1.00  0.00           C  
ATOM     66  OXT MET A   5      -0.338  -4.797  -2.877  1.00  0.00           O  
ATOM     67  H   MET A   5       1.283  -1.124  -1.637  1.00  0.00           H  
ATOM     68  HA  MET A   5       2.096  -3.811  -2.152  1.00  0.00           H  
ATOM     69  HB2 MET A   5      -0.298  -2.963  -0.529  1.00  0.00           H  
ATOM     70  HB3 MET A   5       0.661  -4.425  -0.357  1.00  0.00           H  
ATOM     71  HG2 MET A   5       2.072  -1.848  -0.003  1.00  0.00           H  
ATOM     72  HG3 MET A   5       0.920  -2.317   1.247  1.00  0.00           H  
ATOM     73  HE1 MET A   5       4.163  -2.035   0.328  1.00  0.00           H  
ATOM     74  HE2 MET A   5       5.125  -3.350   1.001  1.00  0.00           H  
ATOM     75  HE3 MET A   5       4.327  -2.203   2.076  1.00  0.00           H  
TER      76      MET A   5                                                      
ENDMDL                                                                          
MASTER       60    0    0    0    0    0    0    6 6000   80    0    1          
END                                                                             
